fda warning letter compounding semaglutide october 2025 Navigating Compounded Semaglutide: What Health Care Providers Need to Know Beyond the Headlines: FDA Warning

In the digestive system, it slows gastric emptying the rate at which food leaves the stomach prolonging feelings of fullness and reducing the postprandial blood sugar spikes that drive hunger and cravings

Consideration should be made to stop semaglutide if less than 5% of the initial weight has been lost after 6 months of treatment

The order underscores the confidentiality of medical and financial information

Integrating Lifestyle Changes for Long-Term Success Medication is a powerful tool, but it is most effective when used as part of a comprehensive lifestyle change

It has anti-ulcer and anti-inflammatory effects (Chang CH, 2011)